STONE HEISZ LESLIE

Track

Insider profile

Performance

Overall performance
2.9
Performance over holding periods
2.9
30 days 90 days 120 days
Average return -0% 8.2% 15.1%
Success rate 78% 68% 82%
Transactions
7 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
STONE HEISZ LESLIE's trades of Edwards Lifesciences Corp's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-12-12 2025-12-12
PrS Proposed sale
82,565
95.13
US$2,850,016 		82,565 95.13 US$2,850,016
2025-12-12 2025-12-12
S Sale
35,176 -45.1%
392.29
US$2,315,273 		35,176 -45.1% 392.29 US$2,315,273
2025-02-13 2025-02-13
PrS Proposed sale
28,386
213.48
US$645,379 		28,386 213.48 US$645,379
2025-02-13 2025-02-13
S Sale
5,739 -16.0%
75.86
US$435,371 		5,739 -16.0% 75.86 US$435,371
2024-07-11 2024-07-11
PrS Proposed sale
250
295.22
US$73,805 		250 295.22 US$73,805
2024-07-02 2024-07-02
PrS Proposed sale
318
285.07
US$90,652 		318 285.07 US$90,652
2024-02-08 2024-02-08
PrS Proposed sale
7,056
86.45
US$609,991 		7,056 86.45 US$609,991
2024-02-08 2024-02-08
S Sale
7,056 -20.7%
86.45
US$609,991 		7,056 -20.7% 86.45 US$609,991
2023-08-10 2023-08-10
PrS Proposed sale
3,303
78.87
US$260,508 		3,303 78.87 US$260,508
2023-08-10 2023-08-10
S Sale
3,303 -10.9%
78.87
US$260,509 		3,303 -10.9% 78.87 US$260,509
2023-02-16 2023-02-16
S Sale
9,671 -26.0%
76.82
US$742,942 		9,671 -26.0% 76.82 US$742,942
2021-12-17 2021-12-15
S Sale
9,045 -79.3%
362.26
US$3,276,642 		9,045 -79.3% 362.26 US$3,276,642
2021-04-23 2021-04-23
S Sale
6,707 -22.9%
97.52
US$654,067 		6,707 -22.9% 97.52 US$654,067